⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 32 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 32 minutes ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT November 27, 2025

Blopress 32 mg - Tabletten 32 mg (Tablette)

📷 Wikipedia: Candesartan · Source
Blopress 32 mg - Tabletten 32 mg (Tablette)
📷 Wikipedia: Candesartan · Source
Blopress 32 mg tablets are temporarily unavailable. No new supplies are expected until February 2029.
🗄
Archived (older alert)
This alert was reported 288 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
116 days in total
May 18, 2026 September 11, 2026

What is this? Blopress 32 mg is a tablet that contains the medicine candesartan cilexetil. It is used for blood pressure.

What's happening? The tablets are not available right now. They will be back in stock in February 2029.

Does this affect me? If you take this medicine in Austria, you may not be able to get it until 2029.

What should I do? Ask your pharmacist or doctor for advice before stopping or changing your medicine.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
CANDESARTAN CILEXETIL
Agency-published detail

ATC: C09CA06 · Reason: Vorübergehende Einstellung des Inverkehrbringens · Marketing authorisation holder: Cheplapharm Arzneimittel GmbH, Ziegelhof 24, 17489 Greifswald, Federal Republic of Germany · Affected packs: 28 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-02-08, resupply 2029-02-07]

First published
November 27, 2025
Last refreshed by us
3 months ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 3 days ago

Candecam 8 mg/5 mg Tabletten 8/5 mg/mg (Tablette)

ATC: C09DB07 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: HCS B.V., Hendrik Kennisstraat 53, 2650 Edegem, Kingdom of Belgium · Affected packs: 28 Stück Schachtel, Bliste...
Low AT resolved 1 month ago

Candesartan/HCT 1A Pharma 8 mg/12,5 mg - Tabletten 8 mg/12,5 mg (Tablette)

Candesartan/HCT 1A Pharma 8 mg/12.5 mg tablets are unavailable since 27 July 2026.
Medium AT resolved 2 months ago

Candesartan/Amlodipin 1A Pharma 16 mg/10 mg – Hartkapseln 16 mg/10 mg (Hartkapsel)

Candesartan/Amlodipine 1A Pharma 16 mg/10 mg hard capsules are unavailable due to manufacturing capacity issues.
Medium AT resolved 2 months ago

Candesartan Krka 32 mg Tabletten 32 mg (Tablette)

Parallel export ban in effect. Supply delayed due to manufacturing issues. Affected packs: 30-tablet box and blister pack, unavailable since 17 June 2026, next resupply 31 July 2026.
Medium AT resolved 3 months ago

Candesartan Sandoz 32 mg - Tabletten 32 mg (Tablette)

Candesartan Sandoz 32 mg tablets are currently unavailable due to manufacturing capacity issues.
Low AT resolved 3 months ago

Candesartan 1A Pharma 32 mg - Tabletten 32 mg (Tablette)

Candesartan 1A Pharma 32 mg tablets are unavailable due to manufacturing shortages.
Low AT resolved 3 months ago

Candesartan/HCT 1A Pharma 32 mg/25 mg - Tabletten 32 mg/25 mg (Tablette)

Parallel export ban in effect. Tablets unavailable since 18 May 2026.
High AT resolved 9 months ago

Blopress Plus 32 mg/25 mg - Tabletten 32/25 mg/mg (Tablette)

Blopress Plus 32 mg/25 mg tablets are temporarily unavailable due to a halt in distribution. No new supply is expected until December 5, 2028.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Blopress 32 mg - Tabletten 32 mg (Tablette). Blopress 32 mg tablets are temporarily unavailable. No new supplies are expected until February 2029.
▸ When was this alert issued?
This alert was issued on November 27, 2025 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.